Cancer Nanomedicine and Immune System—Interactions and Challenges

Cancer Nanomedicine and Immune System—Interactions and Challenges

Nanoparticles have tremendous therapeutic potential in the treatment of cancer as they increase drug delivery, attenuate drug toxicity, and protect drugs from rapid clearance. Since Doxil®, the first FDA-approved nanomedicine, several other cancer nanomedicines have been approved and have successful...

Full description

Bibliographic Details
Main Authors: Suhana Ahmad, Ros Akmal Mohd Idris, Wan Nurhidayah Wan Hanaffi, Komathi Perumal, Jennifer C. Boer, Magdalena Plebanski, Juhana Jaafar, Jit Kang Lim, Rohimah Mohamud
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-07-01
Series:Frontiers in Nanotechnology
Subjects:
tumor micoenvironment
immunogenicity
hypersensitivity
cytotoxicity
drug development
Online Access:https://www.frontiersin.org/articles/10.3389/fnano.2021.681305/full

Internet

https://www.frontiersin.org/articles/10.3389/fnano.2021.681305/full

Similar Items